Crown Reserve Acquisition Corp. I

Definitive Agreement
CIK: 2070887•Ticker: CRAC

SPAC Overview

$150M
IPO Size
$176M
Trust (as of 2026-06-30)
Definitive Agreement
Current Status
2025
IPO Year

Timeline Progress

About

Crown Reserve Acquisition Corp. I is a blank-check company seeking to acquire an unidentified business. It takes a generalist approach, with particular emphasis on pharma, medical technology and medical equipment, and healthcare IT.

Investment Focus

Biopharmaceuticals, Healthcare

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Extended Team Information

The team has experience as executives, entrepreneurs, investors and advisors. CEO Prashant Patel is a pharmacist and healthcare entrepreneur with prior SPAC advisory experience; CFO Eric Sherb brings accounting, auditing, M&A, IPO and SEC reporting experience. Its director nominees have experience in healthcare, pharmaceuticals, energy, technology, finance and SPAC boards.

Stock Performance

CRACU
Trading Symbol
First Trade
November 7, 2025
$10.04
Current Price
September 30, 2026
$10.34
+3%

Key Information

IPO Date
November 6, 2025
PIPE
$80M
State of Incorporation
E9
SIC
6770
Merger Target
Carvix, Inc.
SPAC Ticker
CRAC